Part A: Mean Change From Baseline in Blood Pressure (BP)
A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis · Source last updated 2019-09-23
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Measure
MEAN
Unit
Millimeter of mercury
Interval / dispersion
Standard Deviation
Time frame
Baseline (pre-dose) and 15, 30 minutes, 1, 2, 4, 6, 8, 12, 24, 48 and 72 hours post-dose
What was measured
Systolic BP and diastolic BP were measured in semi-supine position after 5 min rest for the participants at indicated time points. Baseline is defined as the latest available assessment pre the first dose of study drug within each period in Part A. Change from Baseline was calculated as any visit post Baseline value minus Baseline value.
Analysis population: Safety population.
Groups in this outcome
Part A: GSK3039294 200 mg
Participants received a single dose of GSK3039294 (dose level 1) 200 mg capsules, orally, once on Day 1 and stayed in-house until Day 4 in cohort 1.
Part A: GSK3039294 600 mg
Participants received a single dose of GSK3039294 (dose level 2) 600 mg capsules, orally, once on Day 1 and stayed in-house until Day 4 in cohort 1. The remaining participants received the same dose of GSK3039294 (dose level 3) 600 mg, capsules, orally, once on Day 1 and stayed in-house until Day 4 in cohort 2. A washout period was maintained from Day 5 to 14 between two treatment cohorts.
Part A: GSK3039294 1200 mg
Participants received a single dose of GSK3039294 (dose level 4) 1200 mg, capsules, orally, once on Day 1 and stayed in-house until Day 4 in cohort 2.
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
Group
Source count
Part A: GSK3039294 200 mg
8
Part A: GSK3039294 600 mg
16
Part A: GSK3039294 1200 mg
8
Reported measurements
Diastolic BP: 15 minutes
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-0.6
3.11
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-0.4
3.86
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
3.5
4.86
Not reported
Not reported
Not reported
Diastolic BP: 30 minutes
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-0.1
1.54
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
0.1
3.72
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
2.9
4.04
Not reported
Not reported
Not reported
Diastolic BP: 1 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-2.0
4.13
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-1.1
3.53
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
0.9
4.25
Not reported
Not reported
Not reported
Diastolic BP: 2 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-3.1
3.16
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-1.7
4.95
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
1.4
4.06
Not reported
Not reported
Not reported
Diastolic BP: 4 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-7.3
2.45
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-6.5
5.83
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
-2.5
6.54
Not reported
Not reported
Not reported
Diastolic BP: 6 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-4.7
3.82
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-4.8
4.80
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
-0.3
4.38
Not reported
Not reported
Not reported
Diastolic BP: 8 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-2.0
5.47
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-1.9
6.16
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
0.8
6.09
Not reported
Not reported
Not reported
Diastolic BP: 12 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-7.1
2.88
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-4.6
5.77
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
-2.6
7.39
Not reported
Not reported
Not reported
Diastolic BP: 24 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-1.6
4.48
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-2.6
5.52
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
2.5
4.25
Not reported
Not reported
Not reported
Diastolic BP: 48 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-3.0
2.69
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-2.1
6.35
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
0.0
6.24
Not reported
Not reported
Not reported
Diastolic BP: 72 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-4.7
3.82
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-3.2
5.54
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
-0.0
3.99
Not reported
Not reported
Not reported
Systolic BP: 15 minutes
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-2.0
5.08
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
0.8
4.74
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
1.0
4.12
Not reported
Not reported
Not reported
Systolic BP: 30 minutes
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-0.7
4.46
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-0.8
4.59
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
1.7
1.86
Not reported
Not reported
Not reported
Systolic BP: 1 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-1.2
5.79
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
0.2
3.85
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
0.7
2.40
Not reported
Not reported
Not reported
Systolic BP: 2 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-2.6
5.38
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
0.7
5.77
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
1.8
4.87
Not reported
Not reported
Not reported
Systolic BP: 4 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-3.9
5.84
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
0.1
6.65
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
3.6
7.27
Not reported
Not reported
Not reported
Systolic BP: 6 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-2.3
6.62
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
-1.1
5.91
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
1.2
6.09
Not reported
Not reported
Not reported
Systolic BP: 8 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-2.0
9.37
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
1.5
8.50
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
3.8
7.62
Not reported
Not reported
Not reported
Systolic BP: 12 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-3.2
5.70
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
0.1
7.54
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
3.6
7.72
Not reported
Not reported
Not reported
Systolic BP: 24 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-2.8
5.06
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
0.1
5.64
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
4.3
6.75
Not reported
Not reported
Not reported
Systolic BP: 48 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-2.2
4.83
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
0.5
4.88
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
3.3
7.55
Not reported
Not reported
Not reported
Systolic BP: 72 hour
Values in Millimeter of mercury · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part A: GSK3039294 200 mg
-1.1
7.84
Not reported
Not reported
Not reported
Part A: GSK3039294 600 mg
3.4
6.58
Not reported
Not reported
Not reported
Part A: GSK3039294 1200 mg
6.0
5.42
Not reported
Not reported
Not reported
Complete source fields
classes
categories
measurements
group Id
OG000
spread
3.11
value
-0.6
group Id
OG001
spread
3.86
value
-0.4
group Id
OG002
spread
4.86
value
3.5
title
Diastolic BP: 15 minutes
categories
measurements
group Id
OG000
spread
1.54
value
-0.1
group Id
OG001
spread
3.72
value
0.1
group Id
OG002
spread
4.04
value
2.9
title
Diastolic BP: 30 minutes
categories
measurements
group Id
OG000
spread
4.13
value
-2.0
group Id
OG001
spread
3.53
value
-1.1
group Id
OG002
spread
4.25
value
0.9
title
Diastolic BP: 1 hour
categories
measurements
group Id
OG000
spread
3.16
value
-3.1
group Id
OG001
spread
4.95
value
-1.7
group Id
OG002
spread
4.06
value
1.4
title
Diastolic BP: 2 hour
categories
measurements
group Id
OG000
spread
2.45
value
-7.3
group Id
OG001
spread
5.83
value
-6.5
group Id
OG002
spread
6.54
value
-2.5
title
Diastolic BP: 4 hour
categories
measurements
group Id
OG000
spread
3.82
value
-4.7
group Id
OG001
spread
4.80
value
-4.8
group Id
OG002
spread
4.38
value
-0.3
title
Diastolic BP: 6 hour
categories
measurements
group Id
OG000
spread
5.47
value
-2.0
group Id
OG001
spread
6.16
value
-1.9
group Id
OG002
spread
6.09
value
0.8
title
Diastolic BP: 8 hour
categories
measurements
group Id
OG000
spread
2.88
value
-7.1
group Id
OG001
spread
5.77
value
-4.6
group Id
OG002
spread
7.39
value
-2.6
title
Diastolic BP: 12 hour
categories
measurements
group Id
OG000
spread
4.48
value
-1.6
group Id
OG001
spread
5.52
value
-2.6
group Id
OG002
spread
4.25
value
2.5
title
Diastolic BP: 24 hour
categories
measurements
group Id
OG000
spread
2.69
value
-3.0
group Id
OG001
spread
6.35
value
-2.1
group Id
OG002
spread
6.24
value
0.0
title
Diastolic BP: 48 hour
categories
measurements
group Id
OG000
spread
3.82
value
-4.7
group Id
OG001
spread
5.54
value
-3.2
group Id
OG002
spread
3.99
value
-0.0
title
Diastolic BP: 72 hour
categories
measurements
group Id
OG000
spread
5.08
value
-2.0
group Id
OG001
spread
4.74
value
0.8
group Id
OG002
spread
4.12
value
1.0
title
Systolic BP: 15 minutes
denoms
counts
group Id
OG000
value
8
group Id
OG001
value
16
group Id
OG002
value
8
units
Participants
description
Systolic BP and diastolic BP were measured in semi-supine position after 5 min rest for the participants at indicated time points. Baseline is defined as the latest available assessment pre the first dose of study drug within each period in Part A. Change from Baseline was calculated as any visit post Baseline value minus Baseline value.
dispersion Type
Standard Deviation
groups
description
Participants received a single dose of GSK3039294 (dose level 1) 200 mg capsules, orally, once on Day 1 and stayed in-house until Day 4 in cohort 1.
id
OG000
title
Part A: GSK3039294 200 mg
description
Participants received a single dose of GSK3039294 (dose level 2) 600 mg capsules, orally, once on Day 1 and stayed in-house until Day 4 in cohort 1. The remaining participants received the same dose of GSK3039294 (dose level 3) 600 mg, capsules, orally, once on Day 1 and stayed in-house until Day 4 in cohort 2. A washout period was maintained from Day 5 to 14 between two treatment cohorts.
id
OG001
title
Part A: GSK3039294 600 mg
description
Participants received a single dose of GSK3039294 (dose level 4) 1200 mg, capsules, orally, once on Day 1 and stayed in-house until Day 4 in cohort 2.
id
OG002
title
Part A: GSK3039294 1200 mg
param Type
MEAN
population Description
Safety population.
reporting Status
POSTED
time Frame
Baseline (pre-dose) and 15, 30 minutes, 1, 2, 4, 6, 8, 12, 24, 48 and 72 hours post-dose
title
Part A: Mean Change From Baseline in Blood Pressure (BP)